Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna Inc., Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Shannon Thyme Klinger will join the Company as Chief Legal Officer, e…
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova® for the eye care market and CelleRx® Clinical Reset™ for the beauty market, announces that management will …
Globally recognized authority on lifestyle medicine joins ChromaDex SAB to bolster company’s healthy aging research efforts
LOS ANGELES–(BUSINESS WIRE)–$CDXC #CellularHealth–ChromaDex Corp. (NASDAQ:CDXC) announced today it has appointed David L. K…
Globally recognized authority on lifestyle medicine joins ChromaDex SAB to bolster company’s healthy aging research efforts
LOS ANGELES–(BUSINESS WIRE)–$CDXC #CellularHealth–ChromaDex Corp. (NASDAQ:CDXC) announced today it has appointed David L. K…
Globally recognized authority on lifestyle medicine joins ChromaDex SAB to bolster company’s healthy aging research efforts
LOS ANGELES–(BUSINESS WIRE)–$CDXC #CellularHealth–ChromaDex Corp. (NASDAQ:CDXC) announced today it has appointed David L. K…
Actively involved in over 200 clinical trials
30 years experience in managing clinical trials and FDA interactions, leveraging biostatistics PhD
Founding partner of multiple CROs
STAFFORD, Texas–(BUSINESS WIRE)–Greenwich LifeSciences, Inc. (Na…
TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its shares commence trading on the OTCQB® Venture Market (the “OTCQB…
TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its shares commence trading on the OTCQB® Venture Market (the “OTCQB…
DUBLIN–(BUSINESS WIRE)–The “Hepatitis D – Market Insight, Epidemiology and Market Forecast – 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering.
This report delivers an in-depth understanding of the HDV, historical and forecast…
DUBLIN–(BUSINESS WIRE)–The “Global Renal Cell Carcinoma Clinical Trial Pipeline Highlights – 2021” report has been added to ResearchAndMarkets.com’s offering.
The latest report Renal Cell Carcinoma Pipeline Highlights – 2021, provides the most up-to…